Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19029770rdf:typepubmed:Citationlld:pubmed
pubmed-article:19029770lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:19029770lifeskim:mentionsumls-concept:C0997643lld:lifeskim
pubmed-article:19029770lifeskim:mentionsumls-concept:C0022949lld:lifeskim
pubmed-article:19029770lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:19029770lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:19029770pubmed:issue5lld:pubmed
pubmed-article:19029770pubmed:dateCreated2008-11-25lld:pubmed
pubmed-article:19029770pubmed:abstractTextWe investigated the production of galactooligosaccharides (GOS) from lactose by alginate-immobilized cells of Sporobolomyces singularis YIT 10047 (IM-SS). beta-Galactosidase activity was stable at 30 to 50 degrees C but decreased dramatically between 50 and 60 degrees C and disappeared at 70 degrees C in acetate buffer. The enzyme activity remaining was no more than 20% of that of unheated samples after incubation in distilled water at 55 degrees C, whereas its value was about 60% at the same temperature under buffered condition. However, activity was maintained more than 80% with 10% to 50% (w/w) lactose after incubation at 55 degrees C without buffer. In a single-batch reaction, GOS yield was 41.0% with free cells and 40.4% with IM-SS. We attempted a repeated-batch reaction using IM-SS with 600 g L(-1)lactose. IM-SS produced GOS stably for 20 batches (22 h/batch, 440 h in total) at 55 degrees C and pH 5.0 or 6.0. IM-SS produced GOS at 242 g L(-1), at a rate of 8.72 g L(-1) h(-1). Both GOS yield and production rate were higher than those in published experiments on GOS production using immobilized biocatalysts. The repeated-batch reaction with IM-SS would be an ideal system for GOS production because of its stability and high productivity.lld:pubmed
pubmed-article:19029770pubmed:languageenglld:pubmed
pubmed-article:19029770pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19029770pubmed:citationSubsetIMlld:pubmed
pubmed-article:19029770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19029770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19029770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19029770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19029770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19029770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19029770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19029770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19029770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19029770pubmed:statusMEDLINElld:pubmed
pubmed-article:19029770pubmed:monthOctlld:pubmed
pubmed-article:19029770pubmed:issn0022-1260lld:pubmed
pubmed-article:19029770pubmed:authorpubmed-author:SakaiTakafumi...lld:pubmed
pubmed-article:19029770pubmed:authorpubmed-author:HayakawaKazuh...lld:pubmed
pubmed-article:19029770pubmed:authorpubmed-author:TsujiHirokazu...lld:pubmed
pubmed-article:19029770pubmed:authorpubmed-author:MatsumotoKeis...lld:pubmed
pubmed-article:19029770pubmed:authorpubmed-author:ShibataShinya...lld:pubmed
pubmed-article:19029770pubmed:issnTypePrintlld:pubmed
pubmed-article:19029770pubmed:volume54lld:pubmed
pubmed-article:19029770pubmed:ownerNLMlld:pubmed
pubmed-article:19029770pubmed:authorsCompleteYlld:pubmed
pubmed-article:19029770pubmed:pagination285-93lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:meshHeadingpubmed-meshheading:19029770...lld:pubmed
pubmed-article:19029770pubmed:year2008lld:pubmed
pubmed-article:19029770pubmed:articleTitleRepeated-batch production of galactooligosaccharides from lactose at high concentration by using alginate-immobilized cells of Sporobolomyces singularis YIT 10047.lld:pubmed
pubmed-article:19029770pubmed:affiliationYakult Central Institute for Microbiological Research, Kunitachi, Tokyo, Japan. takafumi.sakai@yher.belld:pubmed
pubmed-article:19029770pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19029770pubmed:publicationTypeEvaluation Studieslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19029770lld:pubmed